Product Information
SCOPOLAMINE 1 MG/3 DAY PATCH is a generic product labeled by Rhodes Pharmaceuticals L.P., priced at $4.3357 per EA under NDC 42858015070. Its NADAC has been published 88 times since Jan 29, 2025.
FDA first approved this application on May 6, 2024. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
1 mg/3d
Manufacturer
Rhodes Pharmaceuticals L.P.NDC
42858015070
Classification
Generic
Dosage Form
PATCH, EXTENDED RELEASE
Route
TRANSDERMAL
Effective Date
9/23/2026
Active Ingredients
SCOPOLAMINEApproval Type
Generic (ANDA)
FDA Application
ANDA215329FDA Approved
5/6/2024
TE Code
AB
On Market Since
11/1/2024
Pharmacological Classes
Price Statistics
The NADAC for SCOPOLAMINE 1 MG/3 DAY PATCH has been published 88 times since Jan 29, 2025, and over the history we have for it it has declined 16.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $4.3357 per EA |
|---|---|
| All-time high | $5.2404 (Mar 12, 2025) |
| All-time low | $4.3011 (Jul 22, 2026) |
| 52-week high | $5.0709 |
| 52-week low | $4.3011 |
| Median price | $4.8352 |
| Average price | $4.7530 |
| Largest weekly change | -5.7% (Feb 18, 2026) |
| Weeks tracked | 88 |
| Tracking since | Jan 29, 2025 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Rhodes Pharmaceuticals L.P. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Scopolamine market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Anticholinergic class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of SCOPOLAMINE 1 MG/3 DAY PATCH?
The current National Average Drug Acquisition Cost (NADAC) for SCOPOLAMINE 1 MG/3 DAY PATCH, manufactured by Rhodes Pharmaceuticals L.P., is $4.3357 per EA (NDC 42858015070), effective Sep 30, 2026.
How has the price of SCOPOLAMINE 1 MG/3 DAY PATCH changed over time?
Over the history we have for it, the NADAC for SCOPOLAMINE 1 MG/3 DAY PATCH has declined 16.4%. It has been tracked across 88 weekly CMS publications since Jan 29, 2025.
What are the highest and lowest recorded NADAC prices for SCOPOLAMINE 1 MG/3 DAY PATCH?
Since Jan 29, 2025, the NADAC for SCOPOLAMINE 1 MG/3 DAY PATCH has ranged from a low of $4.3011 (Jul 22, 2026) to a high of $5.2404 (Mar 12, 2025), with a median of $4.8352 per EA.
Are there cheaper alternatives to SCOPOLAMINE 1 MG/3 DAY PATCH?
3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as SCOPOLAMINE 1 MG/3 DAY PATCH in a comparable dosage form, but none are currently priced below it.
Who manufactures SCOPOLAMINE 1 MG/3 DAY PATCH?
SCOPOLAMINE 1 MG/3 DAY PATCH (NDC 42858015070) is labeled by Rhodes Pharmaceuticals L.P., and CMS classifies it as a generic product.